Below reiterates how GLP-1 RAs can help manage weight and blood sugars, particularly as GLP-1 activity 6 may be decreased in people with type 2 diabetes
If you want to assess your own metabolic baseline before any protocol, the key markers are: fasting insulin and fasting glucose (calculate HOMA-IR: glucose multiplied by insulin divided by 405, target below 2), high-sensitivity CRP (below 1), ferritin (50 to 100), free T3, and the triglyceride-to-HDL ratio (below 2)
However, the timeline for appetite suppression can vary based on dosage, adherence, metabolic differences, and lifestyle factors
There is no FDA-approved generic semaglutide or tirzepatide for weight-loss programs, Wegovy and Zepbound carry the obesity indication